The effect of progesterone and human interferon alpha-2 on the release of PGF2 alpha and PGE from epithelial cells of human proliferative endometrium.
Progesterone and interferon-like trophoblastic proteins modulate prostaglandin (PG) synthesis from endometrium in early ovine and bovine pregnancy. Enriched epithelial cells were prepared from human endometrium removed in the proliferative phase of menstrual cycle (n = 8). Progesterone at a concentration of 1 microM suppressed PGE release from the cells during the first 24 hours in culture. After 48 hours in culture progesterone at a dose of 100 nM and 1 microM suppressed both the release of PGF2 alpha and PGE from the cells and this suppression was maintained for a further two days. Addition of exogenous 30 microM arachidonic acid (AA) abolished this effect of progesterone on both PGF2 alpha and PGE release. Interferon alpha-2 did not suppress the basal release of PGF2 alpha nor PGE. In the presence of progesterone, interferon alpha-2 attenuated the progesterone mediated suppression of PGF2 alpha but not PGE release from endometrial cells. These findings suggest that progesterone suppresses the basal release of PGs from human endometrium, but unlike the sheep, interferon alpha-2 does not exert this action on human endometrium.
Mitchell
S N
SN
Department of Obstetrics and Gynaecology, University of Cambridge Clinical School, Rosie Maternity Hospital.
Smith
S K
SK
D016718:Arachidonic Acid / Q000378:metabolism; D046508:Culture Techniques; D015237:Dinoprost / Q000378:metabolism*; D004717:Endometrium / Q000378:metabolism*; D004848:Epithelium / Q000378:metabolism; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000494:pharmacology*; D011374:Progesterone / Q000494:pharmacology*; D011458:Prostaglandins E / Q000378:metabolism*; D011994:Recombinant Proteins; D013997:Time Factors
D007370:Interferon Type I; D011458:Prostaglandins E; D011994:Recombinant Proteins; D016718:Arachidonic Acid; D011374:Progesterone; D015237:Dinoprost